Currently, there are 2.80B common shares owned by the public and among those 2.71B shares have been available to trade.
However, the script later moved the day high at 33.85, down -2.23%. The company’s stock has a 5-day price change of -0.98% and -10.41% over the past three months. BP shares are trading -5.71% year to date (YTD), with the 12-month market performance down to -7.89% lower. It has a 12-month low price of $32.51 and touched a high of $40.84 over the same period. BP has an average intraday trading volume of 7.01 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.28%, -4.78%, and -7.57% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of BP plc ADR (NYSE: BP) shares accounts for 11.65% of the company’s 2.80B shares outstanding.
It has a market capitalization of $90.46B and a beta (3y monthly) value of 0.63. The stock’s trailing 12-month PE ratio is 13.20, while the earnings-per-share (ttm) stands at $2.53. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.95% over the week and 1.46% over the month.
Analysts forecast that BP plc ADR (BP) will achieve an EPS of 1.03 for the current quarter, 1.12 for the next quarter and 4.94 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.94 while analysts give the company a high EPS estimate of 0.94. Comparatively, EPS for the current quarter was 1.14 a year ago. Earnings per share for the fiscal year are expected to decrease by -10.71%, and 19.16% over the next financial year.
Wolfe Research was of a view on July 18, 2024 that the stock is Outperform, while Morgan Stanley gave the stock Equal-Weight rating on July 15, 2024, issuing a price target of $49.90- $41.50. Jefferies on their part issued Buy rating on March 04, 2024.
